bioMérieux announces the appointment of Jennifer Zinn as Executive Vice President, Clinical Operations, effective August 1. She succeeds Pierre Boulud, whose appointment to the position of Chief Executive Officer was announced on June 14.

Jennifer Zinn will head up the company's worldwide clinical operations, which encompass the various commercial regions as well as global strategic functions at local level. As a member of the Executive Committee, she will report directly to Pierre Boulud.

Jennifer Zinn joined the French in vitro diagnostics specialist on October 31, 2022 as General Manager and Director of Clinical Operations in North America. She led the launch of the Biofire Spotfire multiplex PCR system in the USA.

Copyright (c) 2023 CercleFinance.com. All rights reserved.